Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday

Published 06/01/2023, 13:03
Updated 06/01/2023, 14:10
© Reuters.  Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
IXIC
-
AMRN
-
TGTB34
-

Benzinga -

  • Piper Sandler cut DraftKings Inc. (NASDAQ: DKNG) price target from $21 to $15. Piper Sandler analyst Matt Farrell maintained an Overweight rating on the stock. DraftKings shares fell 0.2% to $11.46 in pre-market trading.
  • JP Morgan lifted Aflac Incorporated (NYSE: NYSE:AFL) price target from $62 to $66. JP Morgan analyst Jimmy Bhullar maintained a Neutral rating on the stock. Aflac fell 0.6% to close at $71.50 on Thursday.
  • SVB Leerink cut Fate Therapeutics, Inc. (NASDAQ: FATE) price target from $62 to $10. SVB Leerink analyst Daina Graybosch maintained an Outperform rating on the stock. Fate Therapeutics shares fell 49% to $5.60 in pre-market trading.
  • Jefferies slashed the price target on Asana, Inc. (NYSE: ASAN) from $18 to $15. Jefferies analyst Brent Thill maintained a Hold rating on the stock. Asana shares rose 0.3% to $12.17 in pre-market trading.
  • BTIG cut Silvergate Capital Corporation (NYSE: SI) price target from $51 to $21. BTIG analyst Mark Palmer maintained the stock with a Buy. Silvergate Capital shares fell 11.8% to $11.09 in pre-market trading.
  • DA Davidson raised Helen of Troy Limited (NASDAQ: HELE) price target from $126 to $138. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating on the stock. Helen of Troy shares fell 1.4% to $109.38 in pre-market trading.
  • BMO Capital cut Graphite Bio, Inc. (NASDAQ: GRPH) price target from $14 to $7. BMO Capital analyst Kostas Biliouris downgraded the stock from Outperform to Market Perform. Graphite Bio shares fell 49% to $1.56 in pre-market trading.
  • Baird raised Jacobs Solutions Inc. (NYSE: J) price target from $136 to $150. Baird analyst Andrew Wittmann upgraded the stock from Neutral to Outperform. Jacobs Solutions shares fell 1.9% to close at $123.61 on Thursday.
  • Jefferies increased Amarin Corporation plc (NASDAQ: AMRN) price target from $1.3 to $3. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Amarin shares rose 1.6% to close at $1.26 on Thursday.
  • Cowen & Co. boosted Molson Coors Beverage Company (NYSE: TAP) price target from $55 to $60. Cowen & Co. analyst Vivien Azer upgraded the stock from Market Perform to Outperform. Molson Coors Beverage shares rose 1.4% to $50.25 in pre-market trading.
  • Needham boosted Five9, Inc. (NASDAQ: FIVN) price target from $75 to $90. Needham analyst Scott Berg maintained a Buy rating on the stock. Five9 shares fell 4% to close at $66.47 on Thursday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.